Drugs / Dentoxol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05288478 | Apr → Aug 2022 | epidermolysis bullosa, ulcerative stomatitis | University of Chile | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dentoxol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05288478 ↗ |
| Route | Oral | “Dentoxol® is a proprietary mouthrinse that has anti-inflammatory, antimicrobial and analgesic effects.” NCT05288478 ↗ |